Artra Group Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 3/6
Artra Group has been growing earnings at an average annual rate of 21.5%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 14.2% per year. Artra Group's return on equity is 4.4%, and it has net margins of 1.4%.
Wichtige Informationen
21.5%
Wachstumsrate der Gewinne
22.5%
EPS-Wachstumsrate
| Healthcare Wachstum der Industrie | 7.9% |
| Wachstumsrate der Einnahmen | 14.2% |
| Eigenkapitalrendite | 4.4% |
| Netto-Marge | 1.4% |
| Nächste Ertragsaktualisierung | 13 Nov 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Aufschlüsselung der Einnahmen und Ausgaben
Wie Artra Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 24 | 4,440 | 61 | 1,342 | 0 |
| 31 Mar 24 | 4,519 | 88 | 1,356 | 0 |
| 31 Dec 23 | 4,497 | 53 | 1,384 | 0 |
| 30 Sep 23 | 4,429 | -71 | 1,437 | 0 |
| 30 Jun 23 | 4,610 | -44 | 1,495 | 0 |
| 31 Mar 23 | 4,601 | -35 | 1,506 | 0 |
| 31 Dec 22 | 4,671 | 2 | 1,536 | 0 |
| 30 Sep 22 | 4,520 | -236 | 1,503 | 0 |
| 30 Jun 22 | 3,987 | -364 | 1,358 | 0 |
| 31 Mar 22 | 3,645 | -352 | 1,222 | 0 |
| 31 Dec 21 | 3,158 | -351 | 1,060 | 0 |
| 30 Sep 21 | 2,666 | -500 | 904 | 0 |
| 30 Jun 21 | 2,580 | -355 | 859 | 0 |
| 31 Mar 21 | 2,446 | -432 | 842 | 0 |
| 31 Dec 20 | 2,426 | -440 | 859 | 0 |
| 30 Sep 20 | 2,456 | -190 | 873 | 0 |
| 30 Jun 20 | 2,552 | -242 | 884 | 0 |
| 31 Mar 20 | 2,688 | -192 | 914 | 0 |
| 31 Dec 19 | 2,833 | -146 | 886 | 0 |
| 30 Sep 19 | 2,969 | -211 | 861 | 0 |
| 30 Jun 19 | 3,026 | 131 | 898 | 0 |
| 31 Mar 19 | 3,281 | 205 | 917 | 0 |
| 31 Dec 18 | 3,479 | 269 | 957 | 0 |
Qualität der Erträge: 6029 has high quality earnings.
Wachsende Gewinnspanne: 6029 became profitable in the past.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 6029 has become profitable over the past 5 years, growing earnings by 21.5% per year.
Beschleunigtes Wachstum: 6029 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Erträge im Vergleich zur Industrie: 6029 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (9.6%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 6029's Return on Equity (4.4%) is considered low.